
    
      PROTOCOL OUTLINE: This is a randomized, parallel, double blind study. Patients receive 2 gel
      capsules per day of either docosahexaenoic acid (DHA) enriched oil or a placebo oil. Oral DHA
      supplementation continues daily for 3 years.

      All patients are followed every 6 months for the 3 year duration of the study.

      Completion date provided represents the completion date of the grant per OOPD records
    
  